Evidence map›Paper›PMID 26261542›Full record

ArticleInternational journal of clinical and experimental pathology2015

Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts.

Anke Ruedel, Peter Dietrich, Thomas Schubert, Simone Hofmeister, Claus Hellerbrand, Anja Katrin Bosserhoff

RetractedAbstract readRetracted PublicationRetraction Notice
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Anke RuedelInstitute of Pathology, University Hospital Regensburg Franz-Josef-Strauss-Allee 11, D-93053 Regensburg, Germany.
Peter DietrichInstitute for Biochemistry, Biochemistry and Molecular Medicine, University Erlangen Fahrstraße 17, D-91054 Erlangen, Germany.
Thomas SchubertInstitute of Pathology, University Hospital of Erlangen Krankenhausstr.12, D-91054 Erlangen, Germany.
Simone HofmeisterInstitute of Pathology, University Hospital Regensburg Franz-Josef-Strauss-Allee 11, D-93053 Regensburg, Germany.
Claus HellerbrandDepartment of Internal Medicine I, University Hospital Regensburg Franz-Josef-Strauss-Allee 11, D-93053 Regensburg, Germany.
Anja Katrin BosserhoffInstitute for Biochemistry, Biochemistry and Molecular Medicine, University Erlangen Fahrstraße 17, D-91054 Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activated synovial fibroblasts in rheumatoid arthritis (RASF) play a critical role in the pathology of rheumatoid arthritis (RA). Recent studies suggested that deregulation of microRNAs (miRs) affects the development and progression of RA. Therefore, we aimed to identify de-regulated miRs in RASF and to identify target genes that may contribute to the aggressive phenotype of RASF. Quantitative real-time PCR revealed a marked downregulation of miR-188-5p in synovial tissue samples of RA patients as well as in RASF. Exposure to the cytokine interleukine-1β lead to a further downregulation of miR-188-5p expression levels compared to control cells. Re-expression of miR-188-5p in RASF by transient transfection significantly inhibited cell migration. However, miR-188-5p re-expression had no effects on glycosaminoglycan degradation or expression of repellent factors, which have been previously shown to affect the invasive behavior of RASF. In search for target genes of miR-188-5p in RASF we performed gene expression profiling in RASF and found a strong regulatory effect of miR-188-5p on the hyaluronan binding protein KIAA1199 as well as collagens COL1A1 and COL12A1, which was confirmed by qRT-PCR. In silico analysis revealed that KIAA1199 carries a 3'UTR binding site for miR-188-5p. COL1A1 and COL12A1 showed no binding site in the mRNA region, suggesting an indirect regulation of these two genes by miR-188-5p. In summary, our study showed that miR-188-5p is down-regulated in RA in vitro and in vivo, most likely triggered by an inflammatory environment. MiR-188-5p expression is correlated to the activation state of RASF and inhibits migration of these cells. Furthermore, miR-188-5p is directly and indirectly regulating the expression of genes, which may play a role in extracellular matrix formation and destruction in RA. Herewith, this study identified potential novel therapeutic targets to inhibit the development and progression of RA.

Indexed as

KIAA1199miR-188-5pRheumatoid arthritissynovial fibroblasts

Identifiers

PMID26261542
PMCPMC4525876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.